Skip to main content Back to Top
ASHP Print Logo

Practice Advancement Initiative 2030

Since its inception in 2010, ASHP’s Practice Advancement Initiative, or PAI, has resulted in a remarkable partnership with ASHP state affiliates, health systems, and pharmacists to help drive pharmacy practice change at a local level. To build on this momentum, ASHP has launched PAI 2030, which includes 59 streamlined and updated recommendations to promote optimal, safe, and effective medication use, expand pharmacist and technician roles, and implement the latest technologies.

PAI 2030 identifies changes in healthcare over the past 10 years and predicts where they may lead. It addresses information technology, therapeutic advances, patient care-seeking behavior, healthcare payment models, public health challenges, and disruptors in drug distribution and healthcare delivery. Recommendations are intentionally aspirational rather than prescriptive, so practitioners can customize implementation plans for their situation and update as conditions evolve.

Learn more about PAI 2030 at the educational session on Sunday, 12/8/19 at 10:00 a.m., advance AJHP articles, on ASHP TV, and at the Exhibit Hall.

PAI 2030 Education Session

Sunday, 12/8/19, 10:00 a.m. – 11:30 a.m.
Mandalay Bay L, Level 2
Generating National Impact with the Practice Advancement Initiative (PAI) 2030
Activity #: 0204-0000-19-209-L04-P
Activity #: 0204-0000-19-209-L04-T
1.50 Contact Hours | Knowledge-based
Educational Level: General Interest

As the decade mark of the initial PAI event approaches, continuing disruption in healthcare such as rising costs, changing workforce and business models, technological and therapeutic advances, and evolution of practice settings require the profession to evaluate a new set of concepts and recommendations. This is necessary to meet the future demands of patient care coupled with the continued advancement of the pharmacy profession. ASHP sought to critically revise the original sets of PAI recommendations to project the next ten years and beyond in order to align with ASHP’s Vision that medication use will be optimal, safe, and effective for all people all of the time. This session will review and describe the new recommendations.

Learning Objectives:

  • Describe the history of the Practice Advancement Initiative (PAI) and its future direction.
  • Summarize the process of engaging leaders, key constituents, and broader public comment to inform the revision of the PAI recommendations.
  • Discuss major themes associated with the PAI 2030 Recommendations.
  • Describe how the use of the revised recommendations can be applied to your practice setting to assist with advancing pharmacy practice.

Eric Maroyka
Program Chair, Moderator
: Eric M. Maroyka, Pharm.D., BCPS, Director, Center on Pharmacy Practice Advancement, ASHP, Bethesda, MD

John Clark
John S. Clark, Pharm.D., M.S., BCPS, FASHP
, Associate Chief Pharmacy Officer, Clinical Associate Professor, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, MI

Joseph Lassiter
Joseph Lassiter, Pharm.D., M.S., BCPS
, CPHIMS, President, The Robertson Group, Portland, OR

Julie Lanza
Julie F. Lanza, CPhT, CSPT
, Pharmacy Compliance Specialist, Beth Israel Deaconess Medical Center, Boston, MA

Meghan Swarthout
Meghan D. Swarthout, Pharm.D., M.B.A., BCPS
, Division Director, Ambulatory and Care Transitions Pharmacy, The Johns Hopkins Health System, Baltimore, MD

ASHP Experience Center
Visit the ASHP Experience Center in the Exhibit Hall to learn more about PAI 2030 and inquire about ways you can volunteer to be a content contributor for the development of  tools and resources.

Advance Articles in AJHP

Throughout 2020, ASHP and the ASHP Foundation will be releasing resources, tools, and research support for implementation of PAI 2030. Look for specific focused initiatives that will target action through ASHP’s Sections, Forums, state affiliates, and student societies.